Leiden's BIMINI Biotech Secures €3 Million for Innovative Cancer Treatments
Leiden, Tuesday, 14 January 2025.
BIMINI Biotech, a health tech startup in Leiden, received €3 million in seed funding to advance preclinical development of WASp modulator-based cancer treatments for leukemia and lymphoma.